David Kelleher is the founder of 4G Clinical. 4G Clinical has raised $230M in total funding. Latest round: Growth. Backed by Goldman Sachs Asset Management.
David Kelleher is the co-founder and CEO of 4G Clinical, a venture-backed company that provides Randomization and Trial Supply Management (RTSM) software for the global pharmaceutical market. He was named an EY Entrepreneur of the Year 2019 award finalist in New England. Kelleher led the company through a $230 million growth equity round.
Full founder directory · Investor directory · Company funding database · Fundraising library